Document ID: chunk:federal_register_of_legislation:F2024C00988:reg:3
Version: federal_register_of_legislation:F2024C00988
Segment Type: reg
Provision Reference: reg 3
Character Range: 111123–112164

3                                                   After the supply, there are no remaining supplies of pharmaceutical benefits that are authorised by the prescription.  The pharmacist/patient copy.

Orders lodged under section 33
 (5) For the purposes of subsection (1), if the supply is on the basis of an order lodged under section 33, the approved supplier must keep:
 (a) if a CTS claim is made for the supply—the order; and
 (b) if a claim is made for the supply using the manual system referred to in section 99AAA of the Act—the duplicate of the order.

Definition
 (6) In this section:
dangerous drug means a drug or medicinal preparation in respect of which the law of the State or Territory in which the prescription is written provides that a pharmacist who dispenses that drug or medicinal preparation, or who dispenses it on the last of a number of occasions of supply indicated in a prescription for its supply, must take possession of the prescription and cancel it or deliver it to the authority administering that law.